Navigation Links
Erika Schwartz MD Congratulates Oprah Winfrey for Spotlighting Bioidentical Hormones
Date:1/15/2009

For now, she says: "Let's just celebrate the fact that bioidentical hormones are coming out and are finally being considered as viable treatments for feeling lousy. No longer are we hearing that bioidenticals are just a marketing term. Now that is progress!

New York, NY (PRWEB) January 15, 2009 -- Today is a big day for women's health and bioidentical hormones, says Erika Schwartz MD in her latest blog at www.derika.com.

For the first time, she says, mainstream media is acknowledging that women are suffering unnecessarily and that hormone imbalance is an overwhelming handicap that needs attention and legitimate treatments. It can no longer be swept under the rug.

Dr. Erika notes it took someone like Oprah Winfrey, who is suffering from inadequately treated thyroid problems, menopausal hormone loss and its attendant weight gain to blast the hinges off the door to bioidentical hormone therapy.

Acknowledgement is always the precursor to enlightenment, she adds.

Dr. Erika says she hopes Oprah will consider bioidenticals an important ingredient in her commitment to achieving true wellness.

For now, she says: "Let's just celebrate the fact that bioidentical hormones are coming out and are finally being considered as viable treatments for feeling lousy. No longer are we hearing that bioidenticals are just a marketing term. Now that is progress!

"The next step involves educating the medical community about the existence of bioidenticals, providing them with the studies about them, teaching them the difference between how bioidenticals and non-identical hormone molecules work in the human body and making sure they know that bioidenticals are FDA approved and available at your local drugstore."

Dr. Erika says doctors also need to understand the role and usefulness of compounding pharmacies and get involved with who compounds the hormones they prescribe.

Finally, Dr. Erika says, balanced and honest studies must be undertaken on a large scale and in full view that compare the efficacy and safety of bioidenticals to their non-identical counterparts. The era of creating confusion and muddying the waters of hormone therapies has reached its end.

DrErika.com is dedicated to providing an independent, honest view on healthcare topics and issues from a position of devoted patient advocacy.

Its founder, Erika Schwartz MD, is an internationally-recognized patient advocate, practicing physician, expert in conventional and integrative medicine, author of four books and a frequent guest on TV and radio. DrErika.com doesn't tailor its stories to suit sponsors - it does not accept sponsors.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1872574.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation
2. Steve and Paula Mae Schwartz Honored With Publicity Club of New Englands Crystal Bell Award
3. SAND Technology Appoints Zainab Ahmed Schwartz as CFO
4. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
5. Anapol Schwartz Attorney Named to Executive Committee of American Association for Justice
6. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
7. American Heart Association Congratulates Pioneer Heart Surgeon for Being Named Recipient of Congressional Gold Medal Award
8. Mission Pharmacal Congratulates Exemplary Womens Health Researchers
9. Internet2 Congratulates FCC Rural Health Care Pilot Program Grant Awardees
10. SNM congratulates NOPR and its supporting organizations on successful conclusion of project
11. Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: